We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA has signed a memorandum of understanding (MOU) with the Department of Veterans Affairs (VA) in which the two bodies will share information and expertise related to the review and use of devices, drugs and biologics.
The FDA is exempting drugs that will be used for the President's Emergency Plan for AIDS Relief (PEPFAR) from Prescription Drug User Fee Act fees to lessen the financial difficulties associated with developing the products, an agency guidance says.
The Bush administration is cautioning critics of the FDA budget to consider the agency’s long-term plans when assessing the fiscal 2008 budget proposal.
FDA staff say the Critical Path Initiative (CPI) is in trouble, with insufficient funding leaving employees working on the program during their off hours.
The FDA is exempting drugs that will be used for the President’s Emergency Plan for AIDS Relief (PEPFAR) from Prescription Drug User Fee Act fees to lessen the financial difficulties associated with developing the products, an agency guidance says.
FDA staff say the Critical Path Initiative (CPI) is in trouble, with insufficient funding leaving employees working on the program during their off hours. The agency is now looking for increased funding through appropriations and user fees to address the problem.